29 filings
8-K
PYXS
Pyxis Oncology Inc
27 Mar 24
Other Events
4:09pm
8-K
PYXS
Pyxis Oncology Inc
27 Mar 24
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
7:49am
8-K
PYXS
Pyxis Oncology Inc
21 Mar 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
7:44am
8-K
PYXS
Pyxis Oncology Inc
13 Mar 24
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
4:31pm
8-K
PYXS
Pyxis Oncology Inc
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
yl7b15ddxs lvguk
28 Nov 23
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
7:22am
8-K
x5unyz22qe
7 Nov 23
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
4:44pm
8-K/A
h8bpg6x8
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K
sto21hz705veu7h
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
8-K
jaa2sp6wwhnca
11 Aug 23
Pyxis Oncology Reports Financial Results for Second-Quarter 2023
7:25am
8-K
m7ud83ltxzxs0dq3
11 Aug 23
Other Events
6:34am
8-K
pc2i3dhm6prbebzo
30 Jun 23
Departure of Directors or Certain Officers
4:30pm
8-K
kzf25jzs6
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:54pm
8-K
z4ojczwfl4r3g7zouxq
24 May 23
Regulation FD Disclosure
4:53pm
8-K
v0gi9w7
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
8-K
ccpszegcm aiksesfa
11 May 23
Pyxis Oncology Reports Financial Results for the First Quarter 2023
7:16am
8-K
j2z3q1nvcd2mf6
28 Mar 23
Departure of Directors or Certain Officers
4:33pm
8-K
ba9w7u ofq5sg6o45r9
22 Mar 23
Pyxis Oncology Reports Financial Results for the Fiscal Year
7:08am
8-K
w943zdmc3bkjhyzj6zdk
16 Mar 23
Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial
7:48am
8-K
p2kfkk5zn3
1 Dec 22
Pyxis Oncology Announces FDA Clearance of Two IND Applications
7:03am